News
BeOne Medicines ( NASDAQ: ONC) is selling its royalty rights on the worldwide sales, excluding China, of Amgen’s ( NASDAQ: AMGN) cancer drug Imdelltra (tarlatamab-dlle) for up to $950M to Royalty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback